Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FATIMA FAYYAZ

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1962922658
CMS profile
4074412
Location
MARMORA, NJ

General Payments · PY2022–2024

$595.75

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$443.77

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $417.82 17
Education $25.95 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $151.98 2
PY2024 $443.77 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2022 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.20 08/16/2024 Food and Beverage Undisputed 01/23/2026 1105523237 CMS
AstraZeneca Pharmaceuticals LP $25.95 11/25/2024 Education Undisputed 01/23/2026 1104634157 CMS
Boston Scientific Corporation $144.95 10/24/2024 Food and Beverage Undisputed 01/23/2026 1092263318 CMS
Celgene Corporation $16.75 11/22/2024 Food and Beverage Undisputed 01/23/2026 1101150523 CMS
E.R. Squibb & Sons, L.L.C. $16.54 07/26/2024 Food and Beverage Undisputed 01/23/2026 1101522524 CMS
Exelixis Inc. $13.79 10/04/2024 Food and Beverage Undisputed 01/23/2026 1138557828 CMS
Genentech USA, Inc. $18.56 10/11/2024 Food and Beverage Undisputed 01/23/2026 1133011128 CMS
Janssen Biotech, Inc. $15.99 07/19/2024 Food and Beverage Undisputed 01/23/2026 1078359431 CMS
Janssen Biotech, Inc. $15.99 11/11/2024 Food and Beverage Undisputed 01/23/2026 1078359625 CMS
Janssen Biotech, Inc. $18.66 11/25/2024 Food and Beverage Undisputed 01/23/2026 1078359548 CMS
Lilly USA, LLC $16.36 09/20/2024 Food and Beverage Undisputed 01/23/2026 1134967019 CMS
Menarini Silicon Biosystems, Inc. $16.12 11/18/2024 Food and Beverage Undisputed 01/23/2026 1100676174 CMS
Novartis Pharmaceuticals Corporation $24.75 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086956821 CMS
PUMA BIOTECHNOLOGY, INC. $14.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 1113853899 CMS
PUMA BIOTECHNOLOGY, INC. $15.54 08/02/2024 Food and Beverage Undisputed 01/23/2026 1113848631 CMS
Rigel Pharmaceuticals, Inc. $14.79 11/04/2024 Food and Beverage Undisputed 01/23/2026 1145208545 CMS
SpringWorks Therapeutics, Inc. $17.14 11/08/2024 Food and Beverage Undisputed 01/23/2026 1085804176 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.77 12/17/2024 Food and Beverage Undisputed 01/23/2026 1137544657 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.